These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1693342)

  • 1. Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.
    Wong LJ; Tsao GC; Bruce JI; Wong SS
    Experientia; 1990 May; 46(5):461-4. PubMed ID: 1693342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the genetic effects of hycanthone and oxamniquine.
    Ray VA; Holden HE; Ellis JH; Hyneck ML
    J Toxicol Environ Health; 1975 Nov; 1(2):211-7. PubMed ID: 1107579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs.
    Pica-Mattoccia L; Cioli D
    J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of schistosomes to hycanthone and oxamniquine.
    Cioli D; Pica-Mattoccia L; Archer S
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():38-45. PubMed ID: 2638729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of praziquantel versus hycanthone on deoxyribonucleic acid content of hepatocytes in murine schistosomiasis mansoni.
    Botros SS
    Pharmacol Res; 1990; 22(2):219-29. PubMed ID: 2109860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of oxamniquine to the DNA of schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Trans R Soc Trop Med Hyg; 1989; 83(3):373-6. PubMed ID: 2617584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hycanthone and praziquantel on monoamine oxidase and cholinesterases in Schistosoma mansoni.
    Kim RA; Lukacs J; Tanaka RD; MacInnis AJ
    J Parasitol; 1981 Feb; 67(1):20-3. PubMed ID: 7229816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on some derivatives of oxamniquine.
    el-Hamouly W; Pica-Mattoccia L; Cioli D; Schwartz HM; Archer S
    J Med Chem; 1988 Aug; 31(8):1629-31. PubMed ID: 3398000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cell-free protein-synthesizing system from Schistosoma mansoni and a comparison of the effects of hycanthone and praziquantel on this system.
    Lukacs J; Tanaka RD; Kim RA; Macinnis AJ
    J Parasitol; 1980 Jun; 66(3):424-7. PubMed ID: 7391886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
    Pica-Mattoccia L; Novi A; Cioli D
    Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic activities of hycanthone and some other antischistosomal drugs.
    Ong TM
    Mutat Res; 1978; 55(1):43-70. PubMed ID: 368622
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental chemotherapy of Schistosoma curassoni in mice.
    Vercruysse J; Southgate VR; Rollinson D; Hilderson H
    Parasitol Res; 1989; 75(7):559-62. PubMed ID: 2771923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxamniquine and praziquantel on cell mediated immunity in intestinal bilharziasis.
    Madwar MA; El-Fekhakh EA; Montasser MF; Hussein MM; Ahmed MS; Ahmed SE
    J Egypt Soc Parasitol; 1983 Jun; 13(1):277-83. PubMed ID: 6631107
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
    Jansma WB; Rogers SH; Liu CL; Bueding E
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.